IBM Clinical Development Blog

Chinese FDA Tightens Regulatory Controls on Trial Data

[fa icon='calendar'] Aug 5, 2015 3:15:00 PM / by Amy Young posted in Regulations, China

[fa icon="comment"] 0 Comments

Compliance with self-inspection mandate required by August 25th

The China Food and Drug Administration (CFDA) is making a push to ensure the accuracy of clinical trial data and drug quality (as well as proper record-keeping) for its 1,622 currently pending drug registration applications. This includes both imported and local drugs. 

Read More [fa icon="long-arrow-right"]